Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 102
of 6Next
1:

The renal metallothionein expression profile is altered in human lupus nephritis.

Faurschou M, Penkowa M, Andersen CB, Starklint H, Jacobsen S.

Arthritis Res Ther. 2008;10(4):R76. Epub 2008 Jul 6.

PMID: 18601746 [PubMed - in process]

2:

Effect of human anti-DNA antibodies on proximal renal tubular epithelial cell cytokine expression: implications on tubulointerstitial inflammation in lupus nephritis.

Yung S, Tsang RC, Sun Y, Leung JK, Chan TM.

J Am Soc Nephrol. 2005 Nov;16(11):3281-94. Epub 2005 Sep 28.

PMID: 16192422 [PubMed - indexed for MEDLINE]

3:

Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis.

Bastian HM, Roseman JM, McGwin G Jr, Alarcón GS, Friedman AW, Fessler BJ, Baethge BA, Reveille JD; LUMINA Study Group. LUpus in MInority populations: NAture vs nurture.

Lupus. 2002;11(3):152-60.

PMID: 12004788 [PubMed - indexed for MEDLINE]

4:

Correlative insights into immunoexpression of monocyte chemoattractant protein-1, transforming growth factor beta-1 and CD68+ cells in lupus nephritis.

Wagrowska-Danilewicz M, Stasikowska O, Danilewicz M.

Pol J Pathol. 2005;56(3):115-20.

PMID: 16334978 [PubMed - indexed for MEDLINE]

5:

Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus.

Manger K, Manger B, Repp R, Geisselbrecht M, Geiger A, Pfahlberg A, Harrer T, Kalden JR.

Ann Rheum Dis. 2002 Dec;61(12):1065-70.

PMID: 12429536 [PubMed - indexed for MEDLINE]

6:

[Clinical course and prognostic factors in lupus nephropathy]

Gamba G, Quintanilla L, del Bosque MD, Chew-Wong A, Correa-Rotter R.

Rev Invest Clin. 2000 Jul-Aug;52(4):397-405. Spanish.

PMID: 11061101 [PubMed - indexed for MEDLINE]

7:

Tubular lesions and tubular cell adhesion molecules for the prognosis of lupus nephritis.

Daniel L, Sichez H, Giorgi R, Dussol B, Figarella-Branger D, Pellissier JF, Berland Y.

Kidney Int. 2001 Dec;60(6):2215-21.

PMID: 11737595 [PubMed - indexed for MEDLINE]

9:

Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.

Feng X, Wu H, Grossman JM, Hanvivadhanakul P, FitzGerald JD, Park GS, Dong X, Chen W, Kim MH, Weng HH, Furst DE, Gorn A, McMahon M, Taylor M, Brahn E, Hahn BH, Tsao BP.

Arthritis Rheum. 2006 Sep;54(9):2951-62.

PMID: 16947629 [PubMed - indexed for MEDLINE]

10:

Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritis.

Pitashny M, Schwartz N, Qing X, Hojaili B, Aranow C, Mackay M, Putterman C.

Arthritis Rheum. 2007 Jun;56(6):1894-903.

PMID: 17530720 [PubMed - indexed for MEDLINE]

11:

Involvement of renal tubular Toll-like receptor 9 in the development of tubulointerstitial injury in systemic lupus.

Benigni A, Caroli C, Longaretti L, Gagliardini E, Zoja C, Galbusera M, Moioli D, Romagnani P, Tincani A, Andreoli L, Remuzzi G.

Arthritis Rheum. 2007 May;56(5):1569-78.

PMID: 17469139 [PubMed - indexed for MEDLINE]

12:

Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides.

Yellin MJ, D'Agati V, Parkinson G, Han AS, Szema A, Baum D, Estes D, Szabolcs M, Chess L.

Arthritis Rheum. 1997 Jan;40(1):124-34.

PMID: 9008608 [PubMed - indexed for MEDLINE]

13:

The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.

Shen K, Yu Y, Tang Z, Liu Z, Li L.

Chin Med J (Engl). 1997 Jul;110(7):502-7.

PMID: 9594205 [PubMed - indexed for MEDLINE]

14:

Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages.

Hill GS, Delahousse M, Nochy D, Rémy P, Mignon F, Méry JP, Bariéty J.

Kidney Int. 2001 Jan;59(1):304-16.

PMID: 11135084 [PubMed - indexed for MEDLINE]

15:

Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.

Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA.

Ann Rheum Dis. 2005 Mar;64(3):444-8. Epub 2004 Jul 29.

PMID: 15286009 [PubMed - indexed for MEDLINE]

16:

Renal immunofluorescence and the prediction of renal outcome in patients with proliferative lupus nephritis.

Nossent H, Berden J, Swaak T.

Lupus. 2000;9(7):504-10.

PMID: 11035415 [PubMed - indexed for MEDLINE]

17:

Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure.

Faurschou M, Starklint H, Halberg P, Jacobsen S.

J Rheumatol. 2006 Aug;33(8):1563-9.

PMID: 16881113 [PubMed - indexed for MEDLINE]

18:

Proteinuria and tubulointerstitial lesions in lupus nephritis.

Hill GS, Delahousse M, Nochy D, Mandet C, Bariéty J.

Kidney Int. 2001 Nov;60(5):1893-903.

PMID: 11703608 [PubMed - indexed for MEDLINE]

19:

Induction of metallothionein in proximal tubular cells by zinc and its potential as an endogenous antioxidant.

Alscher DM, Braun N, Biegger D, Stuelten C, Gawronski K, Mürdter TE, Kuhlmann U, Fritz P.

Kidney Blood Press Res. 2005;28(3):127-33. Epub 2005 Apr 5.

PMID: 15812196 [PubMed - indexed for MEDLINE]

20:

In vivo gene expression profile analysis of metallothionein in renal cell carcinoma.

Nguyen A, Jing Z, Mahoney PS, Davis R, Sikka SC, Agrawal KC, Abdel-Mageed AB.

Cancer Lett. 2000 Nov 28;160(2):133-40.

PMID: 11053642 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 102
of 6Next